Companies / Cullinan Therapeutics, Inc. / Activity
Activity — Cullinan Therapeutics, Inc.
3 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Ahmed Nadim CEO | Sell | Common Stock | $223.1K | -16K -3.89% | 404,318 0.63% of shares | medium |
| Feb 24, 2026 | Ahmed Nadim CEO | Sell | Common Stock | $195.6K | -14K -3.34% | 390,803 0.61% of shares | medium |
| Feb 18, 2026 | Ahmed Nadim CEO | Grant | Stock Option (Right to Buy) | — | +828K | 828,000 1.29% of shares | low |